MLTX
MoonLake Immunotherapeutics
Company Overview
| Mkt Cap | $3.42B | Price | $10.10 |
| Volume | 2.18M | Change | +2.96% |
| P/E Ratio | -28.7 | Open | $9.83 |
| Revenue | -- | Prev Close | $9.81 |
| Net Income | $-118.9M | 52W Range | $5.95 - $62.75 |
| Div Yield | N/A | Target | $17.08 |
| Overall | 29 | Value | 40 |
| Quality | 39 | Technical | 9 |
No chart data available
Stock Overview
Updated DailyMoonLake Immunotherapeutics (MLTX) is a leading diversified company in the business industry, currently trading at $10.10 with a market capitalization of $3.42 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows MLTX with a volume of 2.18 million shares. The stock opened up 0.20% from yesterday's close of $9.81. Current analyst estimates project earnings of $-3.29 per share for this year, with next year targeting $-3.64.
MLTX demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange.
Key investment considerations for MLTX include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 69.1%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 06:34 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLTX | $10.10 | +3.0% | 2.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get MoonLake Immunotherapeutics Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW